The advantages of targeting ZCCHC24 in mesenchymal-like cells include not only direct inhibition of the expression of a set of genes related to cancer stemness and EMT, including SNAI and NOTCH but also disruption of the auto-amplified gene expression network formed by ZCCHC24 and ZEB1 to maintain CSC traits. The gene discussed is ZEB1; the disease is cancer.